IP Library Granted Patent US 12,673,949
Granted Patent B2
US 12,673,949 · App. 17/897,297 · Granted Jul 7, 2026

Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device

Inventors: Shiro Irisa (Kanagawa, JP); Wataru Sotoyama (Kanagawa, JP); Eigo Miyazaki (Kanagawa, JP); Atsushi Imamura (Kanagawa, JP); Masaru Kinoshita (Kanagawa, JP); Mitsunori Ito (Kanagawa, JP)
Assignee: SAMSUNG DISPLAY CO., LTD.
C07D471/06C07D519/00C07F5/027H10K50/11H10K85/322H10K85/654H10K85/657H10K85/6572H10K2101/10H10K2101/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,673,949
App. No.
17/897,297
Filed
Aug 29, 2022
Granted
Jul 7, 2026
Kind
B2
Art Unit
1786
USPC
428/690
Abstract

Provided are a heterocyclic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device: The substituents in Formula 1 are the same as described in the detailed description.

Claims (43)

1 . A heterocyclic compound represented by Formula 1:

wherein, in Formula 1,

X 1 , X 2 , X 3 , and X 4 are each independently C or N, and at least one of three X 1 (s), four X 2 (s), three X 3 (s), four X 4 (s), or any combination thereof is N,

Y 1 and Y 2 are each independently C or N, and at least one of Y 1 and Y 2 is N,

R 1 , R 2 , R 3 , and R 4 are each independently a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted aryl group having 6 to 14 ring-forming atoms, a substituted or unsubstituted heteroaryl group having 5 to 14 ring-forming atoms, a substituted or unsubstituted amino group, a substituted or unsubstituted arylamino group having 6 to 14 ring-forming atoms, a substituted or unsubstituted heteroarylamino group having 5 to 14 ring-forming atoms, or a substituted or unsubstituted arylboranyl group having 6 to 14 ring-forming atoms,

R 5 is a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted aryl group having 6 to 14 ring-forming atoms, a substituted or unsubstituted heteroaryl group having 5 to 14 ring-forming atoms, a substituted or unsubstituted amino group, a substituted or unsubstituted arylamino group having 6 to 14 ring-forming atoms, a substituted or unsubstituted heteroarylamino group having 5 to 14 ring-forming atoms, a substituted or unsubstituted indolo[3,2,1-jk]carbazolyl group, or —R 51 —R 52 ,

R 51 is a substituted or unsubstituted arylene group having 6 to 14 ring-forming atoms or a substituted or unsubstituted heteroarylene group having 5 to 14 ring-forming atoms,

R 52 is a substituted or unsubstituted amino group, a substituted or unsubstituted arylamino group having 6 to 14 ring-forming atoms, a substituted or unsubstituted hetero arylamino group having 5 to 14 ring-forming atoms, or a substituted or unsubstituted heteroaryl group having 5 to 14 ring-forming atoms,

n1 and n2 are each independently 1, 2, 3, or 4,

m1 and m2 are each independently 1, 2, or 3, and

m3 is 0, 1, or 2.

2 . The heterocyclic compound of claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are each independently a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted biphenylboranyl group, or a monovalent group represented by Formula B1:

wherein, in Formula B1, * indicates a binding site to a neighboring atom.

3 . The heterocyclic compound of claim 1 , wherein at least one of X 1 (s) is N, at least one of X 2 (s) is N, at least one of X 3 (s) is N, and at least one of X 4 (s) is N.

4 . The heterocyclic compound of claim 1 , wherein n1 and n2 are each 3, and

m1 and m2 are each 2.

5 . The heterocyclic compound of claim 1 , wherein, when two of X 1 (s) and two of X 3 (s) are each C, and m1 and m2 are each 2, one of R 1 (s) and one of R 3 (s) are each a hydrogen atom, and another one of R 1 (s) and another one of R 3 (s) are each a substituted or unsubstituted phenyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted biphenylboranyl group, or a monovalent group represented by Formula B1:

wherein, in Formula B1, * indicates a binding site to a neighboring atom.

6 . The heterocyclic compound of claim 1 , wherein, when three of X 2 (s) and three of X 4 (s) are each C, and n1 and n2 are each 3, two of R 2 (s) and two of R 4 (s) are each a hydrogen atom, and another one of R 2 (s) and another one of R 4 (s) are each a substituted or unsubstituted phenyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted biphenylboranyl group, or a monovalent group represented by Formula B1:

wherein, in Formula B1, * indicates a binding site to a neighboring atom.

7 . The heterocyclic compound of claim 1 , wherein m3 is 1 or 2.

8 . The heterocyclic compound of claim 1 , wherein R 5 is a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted indolo[3,2,1-jk]carbazolyl group, a substituted or unsubstituted N,N-diphenylamino group, a substituted or unsubstituted phenoxazinyl group, or —R 51 -R 52 , and

R 51 is a phenylene group, and R 52 is a substituted or unsubstituted N,N-diphenylamino group or a substituted or unsubstituted phenoxazinyl group.

9 . The heterocyclic compound of claim 1 , wherein the heterocyclic compound is represented by one of Group X:

10 . The heterocyclic compound of claim 1 , wherein the heterocyclic compound is a compound of Group I:

11 . The heterocyclic compound of claim 1 , wherein a highest occupied molecular orbital (HOMO) energy level of the heterocyclic compound is about −6.50 eV to about −4.6 eV, and

a lowest unoccupied molecular orbital (LUMO) energy level of the heterocyclic compound is about −4.00 eV to about −2.60 eV.

12 . The heterocyclic compound of claim 1 , wherein a peak of a fluorescence wavelength of the heterocyclic compound is about 440 nm to about 480 nm, and

a full width at half maximum (FWHM) of a peak of a fluorescence spectrum of the heterocyclic compound is about 20 nm or less.

13 . The heterocyclic compound of claim 1 , wherein AEST of the heterocyclic compound is about 0.3 eV or less.

14 . An organic light-emitting device comprising:

a first electrode; a second electrode; an organic layer comprising an emission layer between the first electrode and the second electrode; and

the heterocyclic compound of claim 1 .

15 . The organic light-emitting device of claim 14 , wherein the emission layer comprises the heterocyclic compound.

16 . The organic light-emitting device of claim 15 , wherein the emission layer further comprises a host,

the host is different from the heterocyclic compound, and

the emission layer consists of the host and the heterocyclic compound.

17 . The organic light-emitting device of claim 16 , wherein the host does not emit light, and the heterocyclic compound emits light.

18 . The organic light-emitting device of claim 15 , wherein the emission layer further comprises a host and a dopant,

the host, the dopant, and the heterocyclic compound are different from each other, and

the emission layer consists of the host, the dopant, and the heterocyclic compound.

19 . The organic light-emitting device of claim 18 , wherein the host and the heterocyclic compound each do not emit light, and the dopant emits light.

20 . An electronic apparatus comprising the organic light-emitting device of claim 14 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2025
From: SAMSUNG ELECTRONICS CO., LTD.
To: SAMSUNG DISPLAY CO., LTD.
Reel/Frame 072788/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2022
From: IRISA, SHIRO; SOTOYAMA, WATARU; MIYAZAKI, EIGO; IMAMURA, ATSUSHI; KINOSHITA, MASARU; ITO, MITSUNORI
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 061344/0663 →
Priority Claims (4)
JP 2021-152022 · Sep 17, 2021 · national
KR 10-2021-0154292 · Nov 10, 2021 · national
JP 2021-209340 · Dec 23, 2021 · national
KR 10-2022-0057393 · May 10, 2022 · national
Continuity (1)
Related Publication 20230126543A1 · Apr 27, 2023
References Cited (22)
US 10249832B1 · Takahashi · 2019 [cited by examiner]
US 20040150327A1 · Kawai · 2004 [cited by examiner]
US 20060273714A1 · Forrest · 2006 [cited by examiner]
US 20200006666A1 · Duan · 2020 [cited by examiner]
US 20210359221A1 · Takahashi et al. · 2021 [cited by applicant]
US 20210391552A1 · Liu · 2021 [cited by examiner]
US 20230080626A1 · Korai et al. · 2023 [cited by applicant]
JP 2013147481A · 2013 [cited by applicant]
JP 2021134172A · 2021 [cited by applicant]
JP 2022102050A · 2022 [cited by applicant]
KR 20210119032A · 2021 [cited by examiner]
English translation of KR 20210119032 A obtained from Google Patents. (Year: 2021). [cited by examiner]
Wei, Jinbei, et al. “Indolo [3, 2, 1-jk] carbazole embedded multiple-resonance fluorophors for narrowband deep-blue electroluminescence with EQE≈34.7% and CIEy≈0.085.” Angewandte Chemie 133.22 (2021): 12377-12381. (Year… [cited by examiner]
Kader, Thomas, et al. “Azaindolo [3, 2, 1-jk] carbazoles: New Building Blocks for Functional Organic Materials.” Chemistry—A European Journal 25.17 (2019): 4412-4425. (Year: 2019). [cited by examiner]
English Translation of Office Action dated Feb. 12, 2025, issued in corresponding JP Patent Application No. 2021-209340, 4 pp. [cited by applicant]
Office Action dated Feb. 12, 2025, issued in corresponding JP Patent Application No. 2021-209340, 3 pp. [cited by applicant]
Claude Niebel et al, “Dibenzo[2,3:5,6]pyrrolizino[1,7-bc]indolo[1,2,3-Im]carbazole: . . . ” New Journal of Chemistry (2010), 34(7), 1243-1246. [cited by applicant]
Ganesha Rai et al, “Ionic liquid mediated efficient reduction of nitroarenes . . . ” Tetrahedron Letters, 2005, 46, 3987-3990. [cited by applicant]
Ha Lim Lee et al, “Narrowband and Pure Violet Organic Emitter with a . . . ”, Small (2020), 16(14), 1907569, 5 pp. [cited by applicant]
Mohamed Abboud et al, “Double N-arylation reaction of polyhalogenated . . . ” Beilstein J. Org. Chem. Aug. 2012, 253-258. [cited by applicant]
Taisei Taniguchi et al, “Construction of Nitrogen-Containing Polycyclic Aromatic Compounds by . . . ” Chemistry Letters (2019), 48(9), 1160-1163. [cited by applicant]
Soo-Ghang Ihn et al, “An Alternative Host Material for Long-Lifespan Blue Organic Light-Emitting Diodes Using Thermally Activated Delayed Fluorescence”, Advanced Science, 4(8), 1600502. (2017), 7 pp. [cited by applicant]